Ring finger protein 19A is overexpressed in non-small cell lung cancer and mediates p53 ubiquitin-degradation to promote cancer growth.
Yu ChengYujiao HuHuanxi WangZhi ZhaoXizi JiangYao ZhangJiameng ZhangYue TongXueshan QiuPublished in: Journal of cellular and molecular medicine (2021)
The expression pattern, biological functions and the related mechanisms of the ring finger protein 19A (RNF19A) in non-small cell lung cancer (NSCLC) remain poorly understood. This study aimed to explore the role of RNF19A, as well as the underlying potential mechanism, in the development of NSCLC. Here, we found that RNF19A was overexpressed in NSCLC tissues, and RNF19A expression in NSCLC tissue samples was associated with NSCLC carcinogenesis and poor outcome. RNF19A promoted the proliferation of NSCLC cells and inhibited apoptosis. RNF19A reduced p53, p21 and BAX expression and induced Cyclin D1, CDK4, CDK6 and BCL2 expression. The inhibitory effect of RNF19A knockdown on proliferation was partially rescued by p53 silencing. RNF19A interacted with p53, shortened p53 half-life and mediated p53 ubiquitin-degradation. Collectively, we suggest that RNF19A plays a critical oncogenic role in lung carcinogenesis by disrupting the function of p53. RNF19A may serve as a new biomarker and/or target for NSCLC management.
Keyphrases
- small cell lung cancer
- advanced non small cell lung cancer
- dna damage response
- poor prognosis
- binding protein
- cell cycle arrest
- cell cycle
- brain metastases
- induced apoptosis
- oxidative stress
- cell death
- squamous cell carcinoma
- small molecule
- endoplasmic reticulum stress
- epidermal growth factor receptor
- cell proliferation
- dna repair
- high glucose
- pi k akt